Estimating the potential health economic value of introducing universal opt-out testing for HIV in emergency departments in Italy
Italy faces challenges with late HIV diagnoses, which leads to worse health outcomes and higher healthcare costs. In Italy, the proportion of late diagnoses (i.e., a CD4 count <350 cells/mm3) has increased to 60% in 2020—10% higher than the European average (1). With an estimated 13,000–15,000 undiagnosed HIV cases in Italy, innovative testing strategies are urgently needed Read More >
When will the UK achieve HIV transmission elimination? Modelling the impact of current HIV prevention efforts on progress towards the 2030 elimination goal
In 2019, the previous UK government set the ambitious target of eliminating HIV transmission within the UK by 2030. While great progress has been made in HIV prevention and treatment in the UK, with England reaching the UNAIDS 95-95-95 target in 20231, past evidence suggested that the goal of ‘elimination’ by 2030 is unlikely to Read More >
An Implementation Tool For US Professionals: First Void Urine Self-Sampling for Primary HPV Cervical Cancer Screening
The national coverage of cervical cancer screening in the US is falling, with about 1 in 4 women not up to date with screening1. Under-screened women bear the greatest burden of disease. Evidence shows 60-64% of American women diagnosed with cervical cancer were unscreened, highlighting the need to explore alternative methods to improve access2-4. In Read More >
Self-sampling for cervical cancer screening – what is it and what does evidence from Europe tell us about whether it provides any benefits compared to traditional ways of screening?
Regular screening is crucial for preventing cervical cancer or identifying cancer at an early stage, when treatment is most likely to be successful. Screening is particularly important for women who did not receive the HPV vaccine; in the UK, that means most women over the age of 30. Many European countries, including the UK, have Read More >
Prescribing restrictions for triple therapy in COPD
We are pleased to announce that our study, exploring barriers to accessing triple therapy for COPD management in primary care across Europe, was presented at the 12th International Care Respiratory Group (IPCRG) World Conference in Athens. The research looked at the variation in the pharmacological management of COPD due to payer-driven access criteria for triple Read More >
COPD care: different countries, same issues
Chronic Obstructive Pulmonary Disease (COPD) persists as a major global public health issue demanding urgent attention from policymakers. Despite being preventable and treatable, COPD is the third leading cause of death globally* accounting for 3.3 million deaths worldwide. Aquarius Population Health conducted a qualitative research study with 17 clinical experts involved in COPD management from Read More >
Comparing the costs and diagnostic outcomes of using DNA methylation testing instead of liquid-based cytology within HPV primary cervical cancer screening in the Netherlands.
Publication of our research assessing the potential health and economic benefits of improved management of chronic obstructive pulmonary disease in England, Germany, Canada, and Japan.
Publication of our economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing
Publication of our work evaluating how seizure-free days are related with other quality of life predictors for patients with Dravet Syndrome and their carers.
